What labs should I ask my doctor for?
Ask for labs that change management, not the longest menu. Start with cardiovascular/metabolic risk and basic safety; add specialized labs only when symptoms, medications, family history, or prior abnormalities give the result a job.
Default baseline
Lipids/ApoB, A1c or fasting glucose, CBC/CMP, kidney and liver markers, blood pressure.
Add when there’s a reason
Lp(a) once; TSH, ferritin, B12, vitamin D, hormones, urine albumin/creatinine, or inflammatory tests when history makes them actionable.
Usually skip first
100-marker cash-pay panels, monthly repeats, generic hormone panels, and tests with no action pathway.
The list I’d start with
If you are walking into a normal prevention visit, I would not start with a 100-marker longevity panel. I would start with the tests that classify risk, catch common safety issues, and point to a real next step.
This is the baseline I’d want on the table before arguing about exotic biomarkers.
Cardiovascular risklipid panel, ApoB when available or when risk looks discordant, and Lp(a) once if family history or prevention intensity matters.
Metabolic riskA1c or fasting glucose, plus blood pressure and weight/waist context. Blood pressure is not a lab, but it changes the whole interpretation.
General safetyCBC, CMP, creatinine/eGFR, liver enzymes, electrolytes, and medication/supplement review.
Kidney/cardiometabolic riskurine albumin/creatinine when diabetes, hypertension, kidney disease, or higher cardiometabolic risk makes it relevant.
The add-ons are where judgment matters
This is the interesting part. A lab is not better because it is obscure. It is better when it resolves a specific clinical uncertainty: fatigue, heavy bleeding, neuropathy, bone risk, family history, medication safety, or a result that was abnormal before.
The question I ask is: what would I do if this result came back high, low, or normal? If nobody can answer that, the test is not ready for the first pass.
TSHthyroid symptoms, palpitations, tremor, constipation, weight change, postpartum/perimenopause overlap, thyroid history, or medications that affect thyroid function.
Ferritin/iron studiesheavy periods, anemia, restless legs, endurance training, hair shedding, vegetarian/vegan intake, pregnancy/postpartum context, or prior low iron.
B12vegan or low-animal-food diet, metformin, acid suppression, neuropathy, macrocytosis, anemia, or cognitive/neurologic symptoms that fit.
Vitamin Dbone health risk, malabsorption, limited sun exposure, darker skin at high latitude, osteoporosis risk, or rechecking a treated deficiency. I do not love it as a reflexive wellness screen.
Hormonesirregular cycles, infertility, PCOS features, early menopause, severe vasomotor symptoms, or medication decisions. A generic 'female hormone panel' rarely answers what people hope it will answer.
hsCRP, celiac, autoimmune, cortisol, or inflammatory tests: use them when symptoms, exam, family history, or prior labs point there; not as a fishing expedition.
How I’d ask in the visit
The most useful version is not 'can you order everything?' It is a short clinical setup. It tells your doctor what you are worried about, what runs in the family, what changed recently, and what you are willing to act on.
Try: 'I’m not trying to order every lab. I want a prevention baseline and I want to know if there are deficiencies or safety issues that would change what we do. My main risks are ___. My symptoms are ___. Which labs would you order, and which results would change the plan?'
If your doctor says no to a test, ask the better follow-up: 'What finding or symptom would make that test appropriate later?' That gives you a clinical threshold, not a stalemate.
How often to repeat labs
The repeat schedule should follow the decision. Lipids may need a shorter follow-up after starting or changing lipid therapy. A1c timing depends on diabetes risk and whether treatment is changing. CBC/CMP timing depends on medications, symptoms, and prior abnormalities. Lp(a) is usually a once-or-rarely test because genetics drive most of the level.
For deficiencies, the repeat test should answer whether the treatment worked. For vague optimization panels, monthly testing usually creates a false sense of precision. Most physiology is noisy at that scale.
What I would not do
I would not order a hundred-marker cash-pay panel as a first move. I would not repeat labs monthly just to feel in control. I would not chase every mild out-of-range value without asking whether it is persistent, clinically coherent, and actionable.
I would also be careful with panels that come bundled with a supplement recommendation. That does not mean every marker is useless. It means the business model can bias what gets labeled as urgent.
When this stops being routine prevention
Do not wait for a routine longevity panel if you have chest pain, fainting, severe shortness of breath, black stools, unintentional weight loss, neurologic symptoms, heavy bleeding, pregnancy concerns, or rapidly worsening fatigue. That is diagnostic medicine, not optimization.
In that setting, the right labs may be completely different, and the timing may be same-day or emergency-level. A guide like this is for planned prevention care, not triage.
Clinical lens
How I’d decide
Use this section as a second pass after the main answer, not as homework before you know what the page is saying.
Who it’s for
Adults doing prevention care, changing health habits, starting or adjusting medication, tracking cardiometabolic risk, or trying to understand fatigue, weight change, heavy periods, perimenopause symptoms, family-history risk, kidney risk, or abnormal prior labs.
Who should skip it
Avoid asking for every trendy biomarker without a plan. Huge panels find noise: mild out-of-range values, false positives, cost, anxiety, and follow-up testing that may not change care. Testing is useful when you know what result would change treatment, monitoring, or urgency.
Measure before / after
Start with the baseline risk question, the symptom question, and the intervention timeline. Repeat labs after a medication change, major nutrition or weight change, abnormal result, pregnancy/postpartum context, new symptoms, or a defined treatment trial. Do not repeat because the dashboard is addictive.
What I’d do first
Bring a focused question: 'I want to understand cardiovascular and metabolic risk, and I want to catch deficiencies or safety issues that would change the plan.' Then ask which results would change management and when they should be repeated.
What would change my mind
A test moves onto my default list when it repeatedly changes decisions and has a clear action pathway. I downgrade tests that mostly create expensive ambiguity, especially when no treatment, monitoring plan, or referral follows from the result.
Frequently Asked Questions
Should I ask for ApoB?
Often, yes, if cardiovascular prevention is part of the question. I especially like ApoB when triglycerides are high, insulin resistance is present, family history is concerning, or LDL-C does not seem to match the overall risk picture.
Should I ask for Lp(a)?
Usually once, especially if there is premature heart disease in the family or you are trying to decide how aggressive prevention should be. Lp(a) is mostly genetic, so repeating it often rarely adds much.
Should I ask for vitamin D, B12, or ferritin?
Yes when risk or symptoms fit: low sun or bone risk for vitamin D, vegan diet or metformin/acid suppression for B12, heavy periods or low iron history for ferritin. I would not use them as a reflexive monthly optimization panel.
Do I need to fast?
Not always. Many lipid and A1c checks can be useful without fasting, but fasting can help if triglycerides, fasting glucose, or insulin are part of the decision. Ask before the draw so the result answers the right question.
Can I just order a longevity panel myself?
You can, but the hard part is not buying the test. The hard part is interpreting borderline results without overtreating noise. If you self-order, decide in advance which results would lead to a medication change, a repeat test, a clinician visit, or no action.
References & citations
- 1.2018 AHA/ACC multisociety guideline on management of blood cholesterol
- 2.USPSTF recommendation: screening for prediabetes and type 2 diabetes. 2021
- 3.European Atherosclerosis Society consensus statement on lipoprotein(a). European Heart Journal, 2022
- 4.National Lipid Association Expert Clinical Consensus: role of ApoB in cardiovascular risk management. Journal of Clinical Lipidology, 2024
- 5.American Diabetes Association Standards of Care in Diabetes—2026: cardiovascular disease and risk management
- 6.USPSTF recommendation: screening for vitamin D deficiency in adults. 2021
- 7.USPSTF recommendation: screening for thyroid dysfunction in adults. 2015
Related Guides
Next step
Turn the guide into the right next decision.
If this page raised a real clinical question, start with the practice details. If you are still learning, get the weekly letter. If you are comparing tests, use the testing hub before buying another panel.